510 related articles for article (PubMed ID: 1332849)
21. Demonstration of hCG binding sites and hCG stimulated steroidogenesis in different populations of interstitial cells.
Bhalla VK; Browne ES; Sohal GS
Adv Exp Med Biol; 1987; 219():489-513. PubMed ID: 2829579
[TBL] [Abstract][Full Text] [Related]
22. Tumor necrosis factor alpha inhibits gonadotropin action in cultured porcine Leydig cells: site(s) of action.
Mauduit C; Hartmann DJ; Chauvin MA; Revol A; Morera AM; Benahmed M
Endocrinology; 1991 Dec; 129(6):2933-40. PubMed ID: 1659519
[TBL] [Abstract][Full Text] [Related]
23. A novel mechanism of action of corticotropin releasing factor in rat Leydig cells.
Ulisse S; Fabbri A; Tinajero JC; Dufau ML
J Biol Chem; 1990 Feb; 265(4):1964-71. PubMed ID: 2153673
[TBL] [Abstract][Full Text] [Related]
24. Corticotropin-releasing factor receptors and actions in rat Leydig cells.
Ulisse S; Fabbri A; Dufau ML
J Biol Chem; 1989 Feb; 264(4):2156-63. PubMed ID: 2464587
[TBL] [Abstract][Full Text] [Related]
25. Vasoactive intestinal peptide receptor regulation of cAMP accumulation and glycogen hydrolysis in the human Ewing's sarcoma cell line WE-68.
Van Valen F; Jürgens H; Winkelmann W; Keck E
Cell Signal; 1989; 1(5):435-46. PubMed ID: 2561912
[TBL] [Abstract][Full Text] [Related]
26. Hormonal regulation of androgen biosynthesis by primary cultures of testis cells from neonatal rats.
Meidan R; Lim P; McAllister JM; Hsueh AJ
Endocrinology; 1985 Jun; 116(6):2473-82. PubMed ID: 3888612
[TBL] [Abstract][Full Text] [Related]
27. Adrenomedullin in the rat testis. I: Its production, actions on testosterone secretion, regulation by human chorionic gonadotropin, and its interaction with endothelin 1 in the leydig cell.
Chan YF; O WS; Tang F
Biol Reprod; 2008 Apr; 78(4):773-9. PubMed ID: 18094363
[TBL] [Abstract][Full Text] [Related]
28. Vasoactive intestinal peptide effects on GH3 pituitary tumor cells: high affinity binding, affinity labeling, and adenylate cyclase stimulation. Comparison with peptide histidine isoleucine and growth hormone-releasing factor.
Wood CL; O'Dorisio MS; Vassalo LM; Malarkey WB; O'Dorisio TM
Regul Pept; 1985 Nov; 12(3):237-48. PubMed ID: 3001842
[TBL] [Abstract][Full Text] [Related]
29. Pharmacology, molecular identification and functional characteristics of vasoactive intestinal peptide receptors in human breast cancer cells.
Gespach C; Bawab W; de Cremoux P; Calvo F
Cancer Res; 1988 Sep; 48(18):5079-83. PubMed ID: 2842044
[TBL] [Abstract][Full Text] [Related]
30. Ontogenic development of vasoactive intestinal peptide receptors in rat intestinal cells and liver.
Chastre E; Emami S; Rosselin G; Gespach C
Endocrinology; 1987 Dec; 121(6):2211-21. PubMed ID: 2824182
[TBL] [Abstract][Full Text] [Related]
31. Pituitary adenylate cyclase activating polypeptide stimulates rat Leydig cell steroidogenesis through a novel transduction pathway.
Rossato M; Nogara A; Gottardello F; Bordon P; Foresta C
Endocrinology; 1997 Aug; 138(8):3228-35. PubMed ID: 9231772
[TBL] [Abstract][Full Text] [Related]
32. Expression of the growth hormone-releasing hormone gene and its peptide product in the rat ovary.
Bagnato A; Moretti C; Ohnishi J; Frajese G; Catt KJ
Endocrinology; 1992 Mar; 130(3):1097-102. PubMed ID: 1537276
[TBL] [Abstract][Full Text] [Related]
33. Characterization of insulin and insulin-like growth factor I receptors of purified Leydig cells and their role in steroidogenesis in primary culture: a comparative study.
Lin T; Haskell J; Vinson N; Terracio L
Endocrinology; 1986 Oct; 119(4):1641-7. PubMed ID: 2944738
[TBL] [Abstract][Full Text] [Related]
34. The quantification of steroidogenesis-stimulating activity in testicular interstitial fluid by an in vitro bioassay employing adult rat Leydig cells.
Hedger MP; Robertson DM; de Kretser DM; Risbridger GP
Endocrinology; 1990 Oct; 127(4):1967-77. PubMed ID: 2169409
[TBL] [Abstract][Full Text] [Related]
35. Binding of bovine thyrotropin to receptors in rat testis and its interaction with gonadotropins.
Amir SM; Sullivan RC; Ingbar SH
Endocrinology; 1978 Jul; 103(1):101-11. PubMed ID: 217636
[TBL] [Abstract][Full Text] [Related]
36. Interleukin-2 is a potent inhibitor of Leydig cell steroidogenesis.
Guo H; Calkins JH; Sigel MM; Lin T
Endocrinology; 1990 Sep; 127(3):1234-9. PubMed ID: 2167211
[TBL] [Abstract][Full Text] [Related]
37. Study of species specificity in growth hormone-releasing factor (GRF) interaction with vasoactive intestinal peptide (VIP) receptors using GRF and intestinal VIP receptors from rat and human: evidence that Ac-Tyr1hGRF is a competitive VIP antagonist in the rat.
Laburthe M; Couvineau A; Rouyer-Fessard C
Mol Pharmacol; 1986 Jan; 29(1):23-7. PubMed ID: 3003561
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of hCG-stimulated steroidogenesis in cultured mouse Leydig tumor cells by bisphenol A and octylphenols.
Nikula H; Talonpoika T; Kaleva M; Toppari J
Toxicol Appl Pharmacol; 1999 Jun; 157(3):166-73. PubMed ID: 10373400
[TBL] [Abstract][Full Text] [Related]
39. Beta-endorphin production by the fetal Leydig cell: regulation and implications for paracrine control of Sertoli cell function.
Fabbri A; Knox G; Buczko E; Dufau ML
Endocrinology; 1988 Feb; 122(2):749-55. PubMed ID: 2962854
[TBL] [Abstract][Full Text] [Related]
40. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate.
Solano RM; Carmena MJ; Carrero I; Cavallaro S; Roman F; Hueso C; Travali S; Lopez-Fraile N; Guijarro LG; Prieto JC
Endocrinology; 1996 Jul; 137(7):2815-22. PubMed ID: 8770902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
